Sign inJoin waitlistJoin the waitlist

Lauri Burroughs

Director, Non-Malignant Transplant Program, Seattle Children's Hospital / Fred Hutch · University of Washington School of Medicine

Credentials: · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Pediatrics
1998–2001
Univ of Wisconsin Sch of Med and Public Health
1994–1998

Research

Transplantation outcomes for severe combined immunodeficiency, 2000-2009
New England Journal of Medicine · 2014 · 540 citations
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an…
Blood · 2011 · 226 citations
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or…
Biology of Blood and Marrow Transplantation · 2008 · First of 18 authors · 216 citations

Michael Pulsipher
28 papers
TT
Troy Torgerson
27 papers
Sung-Yun Pai
23 papers
Luigi Notarangelo
21 papers
Morton Cowan
21 papers
Jennifer Puck
20 papers
LG
Linda Griffith
20 papers
Christopher Dvorak
19 papers
Donald Kohn
19 papers
Monica Thakar
17 papers
NK
Neena Kapoor
17 papers
AW
Ann Woolfrey
16 papers

Grants

Nonmyeloablative Allografting for Immunodeficiency & Other Nonmalignant Disorders
National Heart, Lung, and Blood Institute · K23
Contact PI · $545.7K · Fred Hutchinson Cancer Research Center
2007–2011
Primary Immune Deficiency Treatment Consortium
National Institute of Allergy and Infectious Diseases · U54
Project lead · $304.6K · University of California, San Francisco

Clinical trials

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
Principal investigator · Recruiting · Phase 2
Fred Hutchinson Cancer Center
2021–2028
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2009–2020
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2006
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Principal investigator · Completed · Phase 1
Fred Hutchinson Cancer Center
1997–2018